BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 18158768)

  • 81. Near-infrared light stimuli-responsive synergistic therapy nanoplatforms based on the coordination of tellurium-containing block polymer and cisplatin for cancer treatment.
    Li F; Li T; Cao W; Wang L; Xu H
    Biomaterials; 2017 Jul; 133():208-218. PubMed ID: 28441615
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Arsenic trioxide-loaded CalliSpheres:
    Duan X; Zhao G; Han X; Ren J; Li H; Chen P; Wang M; Ju S
    Oncol Rep; 2021 Jul; 46(1):. PubMed ID: 33982781
    [TBL] [Abstract][Full Text] [Related]  

  • 83. The correlation between the methylation of PTEN gene and the apoptosis of osteosarcoma cells mediated by SeHA nanoparticles.
    Wang Y; Qin N; Zhao C; Yuan J; Lu S; Li W; Xiang H; Hao H
    Colloids Surf B Biointerfaces; 2019 Dec; 184():110499. PubMed ID: 31541893
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Antitumor effect of cisplatin incorporated into polylactic acid microcapsules.
    Araki H; Tani T; Kodama M
    Artif Organs; 1999 Feb; 23(2):161-8. PubMed ID: 10027886
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Targeted systemic chemotherapy using magnetic liposomes with incorporated adriamycin for osteosarcoma in hamsters.
    Kubo T; Sugita T; Shimose S; Nitta Y; Ikuta Y; Murakami T
    Int J Oncol; 2001 Jan; 18(1):121-5. PubMed ID: 11115548
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Free-standing poly(L-lactic acid) nanofilms loaded with superparamagnetic nanoparticles.
    Taccola S; Desii A; Pensabene V; Fujie T; Saito A; Takeoka S; Dario P; Menciassi A; Mattoli V
    Langmuir; 2011 May; 27(9):5589-95. PubMed ID: 21456538
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Osteosarcoma growth suppression by riluzole delivery via iron oxide nanocage in nude mice.
    Raghubir M; Rahman CN; Fang J; Matsui H; Mahajan SS
    Oncol Rep; 2020 Jan; 43(1):169-176. PubMed ID: 31789402
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Chemoembolizing hepatocellular carcinoma with microsphere cored with arsenic trioxide microcrystal.
    Kong D; Jiang T; Liu J; Jiang X; Liu B; Lou C; Zhao B; Carroll SL; Feng G
    Drug Deliv; 2020 Nov; 27(1):1729-1740. PubMed ID: 33307843
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Arsenic trioxide enhances radiation response of 9L glioma in the rat brain.
    Kim JH; Lew YS; Kolozsvary A; Ryu S; Brown SL
    Radiat Res; 2003 Dec; 160(6):662-6. PubMed ID: 14689968
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Effective Delivery of Arsenic Trioxide to HPV-Positive Cervical Cancer Cells Using Optimised Liposomes: A Size and Charge Study.
    Akhtar A; Wang SX; Ghali L; Bell C; Wen X
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29617346
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Formulation Comprising Arsenic Trioxide and Dimercaprol Enhances Radiosensitivity of Pancreatic Cancer Xenografts.
    Tang R; Zhu J; Liu Y; Wu N; Han J
    Technol Cancer Res Treat; 2021; 20():15330338211036324. PubMed ID: 34433326
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Self-activated arsenic manganite nanohybrids for visible and synergistic thermo/immuno-arsenotherapy.
    Zhai Y; Liu M; Yang T; Luo J; Wei C; Shen J; Song X; Ke H; Sun P; Guo M; Deng Y; Chen H
    J Control Release; 2022 Oct; 350():761-776. PubMed ID: 36063961
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Effective Metabolic Targeting of Human Osteosarcoma Cells
    Igarashi K; Kawaguchi K; Kiyuna T; Miyake K; Murakami T; Yamamoto N; Hayashi K; Kimura H; Miwa S; Tsuchiya H; Hoffman RM
    Anticancer Res; 2017 Sep; 37(9):4807-4812. PubMed ID: 28870899
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Multifunctional magnetic nanoparticles for targeted delivery.
    Kumar A; Jena PK; Behera S; Lockey RF; Mohapatra S; Mohapatra S
    Nanomedicine; 2010 Feb; 6(1):64-9. PubMed ID: 19446653
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Comparison of optical and power Doppler ultrasound imaging for non-invasive evaluation of arsenic trioxide as a vascular disrupting agent in tumors.
    Alhasan MK; Liu L; Lewis MA; Magnusson J; Mason RP
    PLoS One; 2012; 7(9):e46106. PubMed ID: 23029403
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Synergistic effect of docetaxel combined with cisplatin on inhibiting human osteosarcoma in nude mice.
    Tao H; Tang X; Jin L; Zhao Y; Luo Y; Zhang Z; Cai L; Tao F; Guo W
    Biochem Biophys Res Commun; 2018 Oct; 505(2):372-377. PubMed ID: 30253943
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Magnetic PECA nanoparticles as drug carriers for targeted delivery: synthesis and release characteristics.
    Yang J; Lee H; Hyung W; Park SB; Haam S
    J Microencapsul; 2006 Mar; 23(2):203-12. PubMed ID: 16754376
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Tetra-arsenic oxide (Tetras) enhances radiation sensitivity of solid tumors by anti-vascular effect.
    Park SG; Jung JJ; Won HJ; Kang MS; Seo SK; Choi IW; Eun CK; Ahn KJ; Park CW; Lee SW; Lew YS; Bae IJ; Choi IH
    Cancer Lett; 2009 May; 277(2):212-7. PubMed ID: 19155124
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Tumor accumulation, penetration, and antitumor response of cisplatin-loaded gelatin/poly(acrylic acid) nanoparticles.
    Ding D; Wang J; Zhu Z; Li R; Wu W; Liu B; Jiang X
    ACS Appl Mater Interfaces; 2012 Mar; 4(3):1838-46. PubMed ID: 22364315
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Targeted delivery of anticancer drugs with intravenously administered magnetic liposomes in osteosarcoma-bearing hamsters.
    Kubo T; Sugita T; Shimose S; Nitta Y; Ikuta Y; Murakami T
    Int J Oncol; 2000 Aug; 17(2):309-15. PubMed ID: 10891540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.